Akos Czibere, insider filing for AKTS
Akos Czibere, reporting
AKTS
Aktis Oncology, Inc. SEC filings
Every EDGAR filing for Aktis Oncology, Inc. (AKTS), newest first, with AI summaries and stories.
- Ticker
- AKTS
- CIK
- 2035832
- Latest filing
- Sep 24
Next: earnings expected ~Feb 16
Insider activity
No open-market insider buys in the last 30 days.
Also: 2 open-market sales ($259K), 1 grant or exercise.
Filings
4Aktis Oncology, Inc.AKTSLIVE 144Aktis Oncology, Inc.AKTSLIVE Akos Czibere, planned sale of AKTS shares
Akos Czibere, reporting
10-QAktis Oncology, Inc.AKTSLIVE 8-KAktis Oncology, Inc.AKTSLIVE 4Aktis Oncology, Inc.AKTSLIVE Ken Herrmann, insider filing for AKTS
Ken Herrmann, reporting
4Aktis Oncology, Inc.AKTSLIVE Ken Herrmann, insider filing for AKTS
Ken Herrmann, reporting
144Aktis Oncology, Inc.AKTSLIVE Ken Herrmann, planned sale of AKTS shares
Ken Herrmann, reporting
144Aktis Oncology, Inc.AKTSLIVE Ken Herrmann, planned sale of AKTS shares
Ken Herrmann, reporting
4Aktis Oncology, Inc.AKTSLIVE 2 insider filings
Shulamit Ron-Bigger, insider filing for AKTS
Show all 2
- 4Insider filing for AKTS
- 4Insider filing for AKTS
Shulamit Ron-Bigger, reporting
144Aktis Oncology, Inc.AKTSLIVE 2 Form 144 notices
Akos Czibere, planned sale of AKTS shares
Show all 2
- 144Planned insider sale of AKTS shares
- 144Planned insider sale of AKTS shares
Akos Czibere, reporting
SCHEDULE 13GAktis Oncology, Inc.AKTSLIVE Ownership stake disclosure by Blue Owl Capital Holdings LP
Blue Owl Capital Holdings LP, filed by
10-QAktis Oncology, Inc.AKTSLIVE 8-KAktis Oncology, Inc.AKTSLIVE 4Aktis Oncology, Inc.AKTSLIVE 2 insider filings
Glenn Gormley, insider filing for AKTS
Show all 2
- 4Insider filing for AKTS
- 3New insider at AKTS
Glenn Gormley, reporting
8-KAktis Oncology, Inc.AKTSLIVE 10-KAktis Oncology, Inc.AKTSLIVE SCHEDULE 13DAktis Oncology, Inc.AKTSLIVE Ownership stake disclosure by MPM BIOVENTURES 2018, L.P.
MPM BIOVENTURES 2018, L.P., filed by
SCHEDULE 13DAktis Oncology, Inc.AKTSLIVE Ownership stake disclosure by EcoR1 Capital, LLC
EcoR1 Capital, LLC, filed by
SCHEDULE 13DAktis Oncology, Inc.AKTSLIVE Ownership stake disclosure by ELI LILLY & Co
ELI LILLY & Co, filed by
3Aktis Oncology, Inc.AKTSLIVE ELI LILLY & Co, new insider at AKTS
ELI LILLY & Co, reporting
4Aktis Oncology, Inc.AKTSLIVE 3 insider filings
Todd Foley, insider filing for AKTS
Show all 3
- 4Insider filing for AKTS
- 4Insider filing for AKTS
- 4Insider filing for AKTS
Todd Foley, reporting
SCHEDULE 13DAktis Oncology, Inc.AKTSLIVE Ownership stake disclosure by VV Manager II, LLC
VV Manager II, LLC, filed by
4Aktis Oncology, Inc.AKTSLIVE Oleg Nodelman, insider filing for AKTS
Oleg Nodelman, reporting · EcoR1 Capital, LLC, reporting
4Aktis Oncology, Inc.AKTSLIVE 3 insider filings
Vida Ventures II, LLC, insider filing for AKTS
Show all 3
- 4Insider filing for AKTS
- 4Insider filing for AKTS
- 4Insider filing for AKTS
Vida Ventures II, LLC, reporting · VIDA VENTURES II-A, LLC, reporting
S-8Aktis Oncology, Inc.AKTSLIVE 8-KAktis Oncology, Inc.AKTSLIVE 424B4Aktis Oncology, Inc.AKTSLIVE EFFECTAktis Oncology, Inc.AKTSLIVE 3Aktis Oncology, Inc.AKTSLIVE 15 insider filings
Kyle D. Kuvalanka, new insider at AKTS
Show all 15
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
- 3New insider at AKTS
Kyle D. Kuvalanka, reporting